The data showed older people had less time from when elevated p-tau217 appeared until they began having symptoms compared to younger ones.

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

Researchers aimed at clarifying the mechanism underlying this connection and tracking the fate of glucose in hypoxic animals.

The offering includes the full integration of the ADC technology platform, which will now be offered by Lonza as part of its advanced synthesis portfolio.

On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

A UCLA study found that macrophages rely on interferon gamma signaling from past infections to preserve innate defenses.

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, ...

Jim Tananbaum, MD, Foresite Capital’s founder and CEO, and Michael Rome, PhD, the managing director who leads the firm’s therapeutics investing practice, discuss the firm’s approach to nurturing ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

Researchers say AI can help biologics manufacturers quantify and optimize the carbon footprint of production operations.

According to data shared during SLAS, the platform was instrumental in helping BellBrook Labs identify 13 novel inhibitors of the protein.